UPDATE: Morgan Stanley Downgrades McKesson Corporation to Equal-Weight; Valuation Capped

Morgan Stanley reduced its McKesson Corporation MCK from Overweight to Equal-weight Morgan Stanley commented, "We estimate flattish EBIT growth in CY13 due to lower new exclusive generics and see EPS growth driven by capital deployment vs. operations. With no NT catalyst and premium EV/EBITDA multiple vs. peers & historical average on our below consensus EBIT estimate, share upside looks limited." McKesson Corporatio closed at $88.67 on Thursday.